Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.
de Mascarel I, Bonichon F, MacGrogan G, de Lara CT, Avril A, Picot V, Durand M, Mauriac L, Trojani M, Coindre JM. de Mascarel I, et al. Among authors: de lara ct. Breast Cancer Res Treat. 2000 May;61(2):151-9. doi: 10.1023/a:1006437902770. Breast Cancer Res Treat. 2000. PMID: 10942101
Time for reappraisal of progesterone-receptor testing in breast cancer management.
MacGrogan G, de Mascarel I, Sierankowski G, Mauriac L, Debled M, Durand M, De Lara CT, Avril A, Picot V, Mathoulin-Pélissier S. MacGrogan G, et al. Among authors: de lara ct, de mascarel i. J Clin Oncol. 2005 Apr 20;23(12):2870-1; author reply 2871. doi: 10.1200/JCO.2005.05.241. J Clin Oncol. 2005. PMID: 15838009 No abstract available.
Epithelial atypia: a marker risk of concomitant or subsequent breast carcinoma?
de Mascarel I, MacGrogan G, Vincent-Salomon A, Mathoulin-Pélissier S, Brouste V, Sigal-Zafrani B, Debled M, Mauriac L, de Lara CT. de Mascarel I, et al. Among authors: de lara ct. J Clin Oncol. 2008 Sep 20;26(27):4514-5; author reply 4515. doi: 10.1200/JCO.2008.18.6205. J Clin Oncol. 2008. PMID: 18802166 No abstract available.
An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis.
Bonnet F, Guedj M, Jones N, Sfar S, Brouste V, Elarouci N, Banneau G, Orsetti B, Primois C, de Lara CT, Debled M, de Mascarel I, Theillet C, Sévenet N, de Reynies A, MacGrogan G, Longy M. Bonnet F, et al. Among authors: de lara ct, de reynies a, de mascarel i. BMC Med Genomics. 2012 Nov 27;5:54. doi: 10.1186/1755-8794-5-54. BMC Med Genomics. 2012. PMID: 23186559 Free PMC article.
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.
Quenel-Tueux N, Debled M, Rudewicz J, MacGrogan G, Pulido M, Mauriac L, Dalenc F, Bachelot T, Lortal B, Breton-Callu C, Madranges N, de Lara CT, Fournier M, Bonnefoi H, Soueidan H, Nikolski M, Gros A, Daly C, Wood H, Rabbitts P, Iggo R. Quenel-Tueux N, et al. Among authors: de lara ct. Br J Cancer. 2015 Aug 11;113(4):585-94. doi: 10.1038/bjc.2015.247. Epub 2015 Jul 14. Br J Cancer. 2015. PMID: 26171933 Free PMC article. Clinical Trial.
30 results